These data indicate that the genetic suppression of PGM3 perturbs intracellular levels of the HBP metabolic intermediates in KL co-mutant cells, leading to the reduction of both O-GlcNAcylation and the abundance of tumor-associated glycan structures. The gene discussed is KL; the disease is neoplasm.